Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Eplivanserin + volinanserin) by Terran Biosciences for Unspecified Psychiatric Disorders: Likelihood of Approval
(Eplivanserin + volinanserin) is under clinical development by Terran Biosciences and currently in Phase III for Unspecified Psychiatric Disorders. According...